344457-87-0

Basic information

• Product Name: {2-chloro-4-[(4-fluoro-2-methylphenyl)amino]phenyl}(2-methylphenyl)methanone
• Synonyms: {2-chloro-4-[(4-fluoro-2-methylphenyl)amino]phenyl}(2-methylphenyl)methanone
• CAS NO: 344457-87-0
• Molecular Weight: 353.823
• Mol File: 344457-87-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: {2-chloro-4-[(4-fluoro-2-methylphenyl)amino]phenyl}(2-methylphenyl)methanone(CAS DataBase Reference)
• NIST Chemistry Reference: {2-chloro-4-[(4-fluoro-2-methylphenyl)amino]phenyl}(2-methylphenyl)methanone(344457-87-0)
• EPA Substance Registry System: {2-chloro-4-[(4-fluoro-2-methylphenyl)amino]phenyl}(2-methylphenyl)methanone(344457-87-0)

Safety Data

• Hazardous Substances Data: 344457-87-0(Hazardous Substances Data)

Upstream product

• 344459-21-8 (2-chloro-4-nitrophenyl)(2-methylphenyl)methanone 
• 7073-36-1 2-chloro-4-nitrobenzoyl chloride 
• 99-60-5 2-chloro-4-nitrobenzoic acid 
• 740815-23-0 (4-bromo-2-chlorophenyl)(2-methylphenyl)methanol 
• 529-20-4 2-methylphenyl aldehyde 
• 31928-47-9 4-bromo-2-chloroiodobenzene 
• 452-71-1 4-fluor-2-methylaniline 
• 740815-24-1 (4-bromo-2-chlorophenyl)(2-methylphenyl)methanone 

Downstream Products

• 720685-83-6 [3-chloro-4-(2-methyl-benzoyl)-phenyl]-(4-fluoro-2-methyl-phenyl)-carbamic acid 1-chloro-ethyl ester 
• 720685-89-2 [3-chloro-4-(2-methyl-benzoyl)-phenyl]-(4-fluoro-2-methyl-phenyl)-carbamic acid chloromethyl ester 
• 344458-06-6 2-Chloro-4-(4-fluoro-2-methyl-N-methyl-phenylamino)-2'-methylbenzophenone 

Relevant articles and documents

Rapid and efficient microwave-assisted synthesis of aryl aminobenzophenones using Pd-catalyzed amination

Substituted aryl aminobenzophenone p38 MAP kinase inhibitors were synthesized in good to excellent yields using palladium-catalyzed aryl amination under conditions of microwave irradiation. Various ligands have been screened, and the reaction conditions w

Dermal anti-inflammatory composition

A pharmaceutical composition for dermal application comprises a lipophilic anti-inflammatory compound and a pharmaceutically acceptable vehicle comprising a lipophilic excipient capable of solubilizing the anti-inflammatory compound and targeting said compound to the pilosebaceous ducts on application of the composition on the skin. The composition may be used in the treatment of dermal inflammatory conditions, in particular acne.